| scholarly article | Q13442814 |
| P356 | DOI | 10.1038/SJ.GENE.6363673 |
| P8608 | Fatcat ID | release_pw5vull7unfgtd4xr5syero24m |
| P698 | PubMed publication ID | 11196706 |
| P5875 | ResearchGate publication ID | 12133790 |
| P2093 | author name string | Alvarez C | |
| Rodríguez A | |||
| Alvarez V | |||
| Coto E | |||
| Torre JC | |||
| Zapico I | |||
| P433 | issue | 4 | |
| P921 | main subject | rheumatoid arthritis | Q187255 |
| P304 | page(s) | 288-289 | |
| P577 | publication date | 2000-01-01 | |
| P1433 | published in | Genes and Immunity | Q15745246 |
| P1476 | title | CCR5 (chemokine receptor-5) DNA-polymorphism influences the severity of rheumatoid arthritis. | |
| P478 | volume | 1 |
| Q34389532 | A novel highly potent therapeutic antibody neutralizes multiple human chemokines and mimics viral immune modulation |
| Q47980681 | Analysis of the CC chemokine receptor 5 (CCR5) Delta32 polymorphism in Behçet's disease |
| Q54762826 | Association between polymorphisms in the human chemokine receptor genes CCR2 and CX3CR1 and rheumatoid arthritis. |
| Q47704813 | Association between the chemokine receptor 5 delta32 polymorphism and rheumatoid arthritis: a meta-analysis |
| Q35555826 | Association of polymorphism in the transforming growth factor {beta}1 gene with disease outcome and mortality in rheumatoid arthritis |
| Q54325199 | Association of the CC chemokine receptor 5 (CCR5) polymorphisms with preeclampsia in Turkish women. |
| Q34282309 | Association of the CCR5 gene with juvenile idiopathic arthritis |
| Q99408059 | C-C chemokine receptor type 5 links COVID-19, rheumatoid arthritis, and Hydroxychloroquine: in silico analysis |
| Q36720252 | CCR2 and CCR5 genes polymorphisms in women with cervical lesions from Pernambuco, Northeast Region of Brazil: a case-control study |
| Q37689783 | CCR5 antagonists: the answer to inflammatory disease? |
| Q35693333 | CCR5 blockade is well tolerated and induces changes in the tissue distribution of CCR5+ and CD25+ T cells in healthy, SIV-uninfected rhesus macaques |
| Q36371823 | CCR5 expression influences the progression of human breast cancer in a p53-dependent manner |
| Q33247466 | CCR5 is essential for NK cell trafficking and host survival following Toxoplasma gondii infection |
| Q33677606 | CCR5 is involved in resolution of inflammation in proteoglycan-induced arthritis |
| Q51016561 | CCR5Δ32 (rs333) polymorphism is associated with the susceptibility to systemic lupus erythematosus in female Brazilian patients. |
| Q36786977 | CXCR4-CCR5: a couple modulating T cell functions |
| Q44090321 | Chemokine receptor CCR5: polymorphism at protein level |
| Q34754683 | Chemokine receptor antagonism as an approach to anti-inflammatory therapy: 'just right' or plain wrong? |
| Q46270784 | Chemokine receptor polymorphism in transplantation immunology: no longer just important in AIDS. |
| Q35048804 | Chemokine receptors in inflammation: an overview |
| Q36262470 | Chemokines: their role in rheumatoid arthritis |
| Q54551423 | Differential CCR5Delta32 allelic frequencies in juvenile idiopathic arthritis subtypes: evidence for different regulatory roles of CCR5 in rheumatological diseases. |
| Q37723178 | Dual targeting of CCR2 and CCR5: therapeutic potential for immunologic and cardiovascular diseases |
| Q50582729 | Effects of the CCR5-Delta32 mutation on antiviral treatment in chronic hepatitis C. |
| Q40643961 | Experimental arthritis in CC chemokine receptor 2-null mice closely mimics severe human rheumatoid arthritis |
| Q74286980 | Genetic variation at the chemokine receptors CCR5/CCR2 in myocardial infarction |
| Q47776071 | Increase in CCR5 Delta32/Delta32 genotype in multiple sclerosis. |
| Q38618883 | Inflammatory Cell Migration in Rheumatoid Arthritis: A Comprehensive Review |
| Q79919411 | Influence of CCR5-Delta32 genotype in Spanish population with multiple sclerosis |
| Q47393101 | Inhibition of the development of collagen-induced arthritis in rhesus monkeys by a small molecular weight antagonist of CCR5. |
| Q84651003 | Lack of Association of C-C Chemokine Receptor 5 Δ32 Deletion Status with Rheumatoid Arthritis, Systemic Lupus Erythematosus, Lupus Nephritis, and Disease Severity |
| Q33287486 | Lack of association between the chemokine receptor 5 polymorphism CCR5delta32 in rheumatoid arthritis and juvenile idiopathic arthritis |
| Q33889590 | Low-level laser irradiation treatment reduces CCL2 expression in rat rheumatoid synovia via a chemokine signaling pathway |
| Q36084912 | Maraviroc, a chemokine receptor-5 antagonist, fails to demonstrate efficacy in the treatment of patients with rheumatoid arthritis in a randomized, double-blind placebo-controlled trial |
| Q35014330 | Negative association between the chemokine receptor CCR5-Delta32 polymorphism and rheumatoid arthritis: a meta-analysis |
| Q37270859 | Negative association of the chemokine receptor CCR5 d32 polymorphism with systemic inflammatory response, extra-articular symptoms and joint erosion in rheumatoid arthritis |
| Q84534177 | Peripheral blood T4 cell surface CCR5 density as a marker of activity in rheumatoid arthritis treated with anti-CD20 monoclonal antibody |
| Q37097735 | Polymorphisms of chemokine and chemokine receptor genes in idiopathic immune-mediated posterior segment uveitis |
| Q38102876 | Regulation of TNF-α with a focus on rheumatoid arthritis |
| Q35084899 | Rheumatic manifestations of human immunodeficiency virus infection |
| Q90642824 | Role of Chemokines and Chemokine Receptors in Rheumatoid Arthritis |
| Q81009170 | SDF-1 and CCR5 genes polymorphism in patients with head and neck cancer |
| Q26797338 | T Cell Migration in Rheumatoid Arthritis |
| Q36150612 | Targeting cellular adhesion molecules, chemokines and chemokine receptors in rheumatoid arthritis |
| Q83993234 | The 32-base pair deletion of the chemokine receptor 5 gene (CCR5-Delta32) is not associated with primary sclerosing cholangitis in 363 Scandinavian patients |
| Q34762728 | The CCR5Δ32 polymorphism in Brazilian patients with sickle cell disease |
| Q36801049 | The Development of Novel Therapies for Rheumatoid Arthritis |
| Q47126167 | The HIV co-receptor CCR5 regulates osteoclast function. |
| Q39158831 | The Multifunctional Role of the Chemokine System in Arthritogenic Processes |
| Q53519868 | The chemokine receptor CCR5 genetic polymorphism and expression in rheumatoid arthritis patients. |
| Q36096959 | The complex role of the chemokine receptor CCR2 in collagen-induced arthritis: implications for therapeutic targeting of CCR2 in rheumatoid arthritis |
| Q36360715 | The role of chemokines in rheumatoid arthritis and osteoarthritis |
| Q79440686 | The strength of the chemotactic response to a CCR5 binding chemokine is determined by the level of cell surface CCR5 density |
| Q35140855 | Therapeutic strategies for rheumatoid arthritis |
| Q91909222 | [CCR5 antagonists and HIV-1 infection: Bases and consequences of this therapeutic approach] |
Search more.